A carregar...
Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy
A significant proportion of patients infected with SARS‐CoV‐2 develop severe respiratory symptoms due to an excessive immune response. Treatment of this condition may include immunosuppressive therapies, such as IL‐6 receptor antagonists and corticosteroids, which pose a risk for patients with activ...
Na minha lista:
| Publicado no: | J Viral Hepat |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537127/ https://ncbi.nlm.nih.gov/pubmed/32969557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13410 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|